1.Park JS, Park MC, Song JJ, Park YB, Lee SK, Lee SW. Application of the 2013 ACR/EULAR classification criteria for systemic sclerosis to patients with Raynaud's phenomenon. Arthritis Res Ther. 2015 Mar 22;17(1):77.
2.Park JS, Park MC, Park YB, Lee SK, Lee SW. Concurrent use of methotrexate and celecoxib increases risk of silent liver fibrosis in rheumatoid arthritis patients with subclinical reduced kidney function. Clin Rheumatol 2014;33:1415-23.
3.Park HJ, Ha YJ, Pyo JY, Park YB, Lee SK, Lee SW. Delta neutrophil index as an early marker for differential diagnosis of adult-onset Still's disease and sepsis. Yonsei Med J 2014;55:753-9.
Park HJ, Park MC, Park YB, Lee SK, Lee SW. The concomitant use of meloxicam and methotrexate does not clearly increase the risk of silent kidney and liver damages in patients with rheumatoid arthritis. Rheumatol Int 2014;34:833-40.
4.Pyo JY, Park JS, Park YB, Lee SK, Ha YJ, Lee SW. Delta neutrophil index as a marker for differential diagnosis between flare and infection in febrile systemic lupus erythematosus patients. Lupus. 2013;22:1102-9.
5.Lee SW, Park KH, Park S, Kim JH, Hong SY, Lee SK, Choi D, Park YB. Soluble receptor for advanced glycation end products alleviates nephritis in NZB/WF1 mice. Arthritis Rheum 2013:65:1902-12.
6.Park HJ, Kang MI, Kang Y, Chung SJ, Lee SW, Park YB, Lee SK (Corresponding author). Two Cases of Refractory Thrombocytopenia in Systemic Lupus Erythematosus that Responded to Intravenous Low-Dose Cyclophosphamide. J Korean Med Sci 2013;28:472-5.
7.Lee SW, Park HJ, Kim BK, Han KH, Lee SK, Kim SU, Park YB. Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate. Arthritis Res Ther 2012;14:R232.
8.Lee SW, Park MC, Lee SK, Park YB. The efficacy of brain 18F-fluorodeoxyglucose positron emission tomography in neuropsychiatric lupus patients with normal brain magnetic resonance imaging findings. Lupus 2012;21:1531-7.
9.Lee SW, Park YB, Yang J, Park KH, Lee SK, Choi KH, Kim BS. Attenuation of nephritis in lupus-prone mice by thalidomide. Rheumatology (Oxford). 2012;51:2131-40.
10.Lee SW, Park MC, Lee SK, Park YB. Adjusted neutropenia is associated with early serious infection in systemic lupus erythematosus. Mod Rheumatol 2013;23:509-15.
11.Lee SW, Kim JH, Park MC, Park YB, Chae WJ, Morio T, Lee DH, Yang SH, Lee SK, Lee SK, Lee SK. Alleviation of rheumatoid arthritis by cell-transducible methotrexate upon transcutaneous delivery. Biomaterials 2012;33:1563-72.
12.Lee SW, Kim BS. Comparison of therapeutic efficacy between bortezomib and combination treatment of prednisolone and mycohpenolate mofetil in nephritis in NZB/WF1 mice. Clin Exp Rheumatol 2010;28:393-6.
13.Lee SW, Choi EY, Lee SK, Park YB. E/E' ratio is more sensitive than E/A ratio for detection of left ventricular diastolic dysfunction in patients with systemic sclerosis. Clin Exp Rheumatol 2010;28(2 suppl 58):S12-7.
14.Lee SW, Kim JH, Park YB, Lee SK. Bortezomib attenuates murine collagen-induced arthritis. Ann Rheum Dis 2009;68:1761-7.
15.Lee SW, Park YB, Song JS, Lee SK. The mid-range of the adjusted level of ferritin can predict the chronic course in patients with adult onset Still’s disease. J Rheum 2009;36:156-62.
16.Lee SW, Kim JH, Park MC, Park YB, Lee SK. Adiponectin mitigates the arthritis severity in mice with collagen-induced arthritis. Scan J Rheumatol 2008;37:260-8.
17.Lee SW, Park MC, Park YB, Lee SK. E/E’ ratio is more sensitive than E/A ratio for detection of left ventricular diastolic dysfunction in systemic lupus erythematoisus. Lupus 2008;17:195-201.
18.Lee SW, Park MC, Kim H, Park YB, Lee SK. Dermatopathic lymphadenopathy in a patient with adult onset Still’s disease, Clin Exp Rheumatol 2007;25:312-4.
19.Lee SW, Kwon OJ, Park MC, Oh HB, Park YB, Lee SK. HLA alleles in Korean patients with Takayasu arteritis. Clin Exp Rheumatol 2007;25:S18-22.
20.Lee SW, Park MC, Park YB, Lee SK. Measurement of serum leptin level could assist disease activity monitoring in rheumatoid arthritis. Rheumatol Int 2007;27:537-40.
21.Lee SW, Jung SY, Park MC, Park YB, Lee SK. Malignancies in Korean patients with inflammatory myopathy. Yonsei Med J 2006;47:519-23.
22.Lee SW. Proper time to initiate antiosteoporotic treatment in rheumatoid arthritis with or without glucocorticoid use. Korean J Intern Med. 2014 Jul;29(4):434-6.
23.Lee SW. Clinical manifestations and Diagnosis of Psoriatic arthritis. The Korean Journal of Medicine. 2013;85(3):250-5.
24.Lee SW. Laboratory findings and renal pathology in systemic lupus erythematosus. The Korean Journal of Medicine. 2010;78(4):416-24.
25.Ha YJ, Kang EJ, Lee SW, Park YB, Lee SK, Song JS, Choi ST. Serum leucine-rich α2-glycoprotein is a useful biomarker for monitoring disease activity in patients with adult-onset Still's disease. Scand J Rheumatol. 2015 Jun 16:1-5.
26.Park KH, Mun CH, Kang MI, Lee SW, Lee SK, Park YB. Treatment of collagen-induced arthritis using immune modulatory properties of human mesenchymal stem cells. Cell Transplant. 2015 Apr 7. [Epub ahead of print]
27.Hong SH, Cho JG, Yoon KJ, Lim DS, Kim CH, Lee SW, Park SG. The antibody atliximab attenuates collagen-induced arthritis by neutralizing AIMP1, an inflammatory cytokine that enhances osteoclastogenesis. Biomaterials 2015;44:45-54.
28.Park TY, Park SD, Cho JY, Moon JS, Kim NY, Park K, Seong RH, Lee SW, Morio T, Bothwell AL, Lee SK. RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells. Proc Natl Acad Sci U S A 2014;111:18673-8.
29.Ha YJ, Kang EJ, Lee SW, Lee SK, Park YB, Song JS, Choi ST. Usefulness of serum leucine-rich alpha-2 glycoprotein as a disease activity biomarker in patients with rheumatoid arthritis. J Korean Med Sci. 2014 Sep;29(9):1199-204.
30.Kwon YJ, Lee SW, Park YB, Lee SK, Park MC. Secreted frizzled-related protein 5 suppresses inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes through down-regulation of c-Jun N-terminal kinase. Rheumatology (Oxford) 2014 Apr 24. [Epub ahead of print]
31.Kwon M, Sung M, Kwon YJ, Song YG, Lee SW, Park MC, Park YB, Lee SK, Song JJ. Active tuberculosis risk with tumor necrosis factor inhibitors after treating latent tuberculosis. J Clin Rheumatol 2014;20:68-73.
32.Kang Y, Park JS, Ha YJ, Kang MI, Park HJ, Lee SW, Lee SK, Park YB. Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Schonlein purpura. J Korean Med Sci 2014;29:198-203.
33.Kang Y, Park HJ, Kang MI, Lee HS, Lee SW, Lee SK, Park YB. Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther 2013;15:R194.
34.Kwon YJ, Yoon CH, Lee SW, Park YB, Lee SK, Park MC. Inhibition of glycogen synthase kinase-3β suppresses inflammatory responses in rheumatoid arthritis fibroblast-like synoviocytes and collagen-induced arthritis. Joint Bone Spine. 2014 May;81(3):240-6.
35.Ha YJ, Lee SW, Lee SK, Park YB. Osteoporotic calcaneal stress fractures mistaken for aggravation of rheumatoid arthritis. Arthritis Rheum 2013;65:2983.
36.Pyo JY, Park JS, Song CH, Lee SW, Park YB, Lee SK. Takayasu arteritis associated with ulcerative colitis and optic neuritis: first case in Korea. Korean J Intern Med 2013;28:491-6.
37.Yoon CH, Chung SJ, Lee SW, Park YB, Lee SK, Park MC. Gallic acid, a natural polyphenolic acid, induces apoptosis and inhibits proinflammatory gene expressions in rheumatoid arthritis fibroblast-like synoviocytes. Joint Bone Spine 2013;80:274-9.
38.Yoon CH, Kwon YJ, Lee SW, Park YB, Lee SK, Park MC. Activation of Liver X Receptors Suppresses Inflammatory Gene Expressions and Transcriptional Corepressor Clearance in Rheumatoid Arthritis Fibroblast Like Synoviocytes. J Clin Immunol. 2013;33:190-9.
39.Jung SJ, Kang Y, Ha YJ, Lee KH, Lee SW, Lee SK, Park YB. Application of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis in Korean patients with undifferentiated arthritis. Scand J Rheumatol 2012;41:192-5.
40.Jung SJ, Lee SW, Ha YJ, Lee KH, Kang Y, Park MC, Lee SK, Park YB. Patients with early arthritis who fulfil the 1987 ACR classification criteria for rheumatoid arthritis but not the 2010 ACR/EULAR criteria. Ann Rheum Dis 2012;71:1097-8.
41.Lee KH, Cho A, Choi YJ, Lee SW, Ha YJ, Jung SJ, Park MC, Lee JD, Lee SK, Park YB. The role of (18) F-fluorodeoxyglucose positron emission tomography in the assessment of disease activity in patients with Takayasu’s arteritis. Arthritis Rheum 2012;64:866-75.
42.Song JS, Do JH, Lee SW. The prevalence and the clinical relevance of anti-Ro52 in Korean patients with primary Sjogren’s syndrome. Rheumatol Int 2012;32:491-5.
43.Ha YJ, Jung SY, Lee KH, Jung SJ, Lee SW, Park MC, Lee SK, Shim WH, Chang BC, Park YB. Long-term clinical outcomes and risk factors for the occurrence of post-operative complications after cardiovascular surgery in patients with Behcet's disease. Clin Exp Rheumatol. 2012 May-Jun;30(3 Suppl 72):
44.Ha YJ, Jung SJ, Lee KH, Lee SW, Lee SK, Park YB. Retroperitoneal fibrosis in 27 Korean patients: single center experience. J Korean Med Sci 2011;26:985-90.
45.Ha YJ, Jung SJ, Lee KH, Lee SW, Lee SK, Park YB. Glucocorticoid-induced diabetes mellitus in patients with systemic lupus erythematosus treated with high-dose glucocorticoid therapy. Lupus 2011;20:1027-34.
46.Lee KH, Son MK, Ha YJ, Choi ST, Lee SW, Park YB, Lee SK. Inflammatory polyarthritis in a patient with psoriasis: is it psoriatic arthritis or rheumatoid arthritis? Korean J Intern Med. 2010 Jun;25(2):224-6.
47.Choi ST, Kim JH, Kang EJ, Lee SW, Park MC, Park YB, Lee SK. Osteopontin might be involved in bone remodeling rather than in inflammation in ankylosing spondylitis. Rheumatology 2008;47:1775-9.
48.Park MC, Lee SW, Choi ST, Park YB, Lee SK. Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis. Scand J Rheumatol 2007;36:101-6.
49.Park MC, Lee SW, Park YB, Lee SK, Choi D, Shim WH. Post-interventional immunosuppressive treatment and vascular restenosis in Takayasu’s arteritis. Rheumatology 2006;45:600-5.
50.Park MC, Lee SW, Park YB, Lee SK. Serum cytokine profiles and their correlations with disease activity in Takayasu’s arteritis. Rheumatology 2006;45:545-8.
51.Choi ST, Park MC, Lee SW, Park YB, Hahn SB, Lee SK. Hand involvement of Mycobacterium tuberculosis infection mimicking rheumatoid arthritis. Clin Exp Rheumatol 2006;24:347.
52.Park MC, Lee SW, Park YB, Chung NS, Lee SK. Clinical characteristics and outcomes of Takayasu’s arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment and angiographic classification. Scand J Rheumatol 2005;34:284-92.